Apremilast (Otezla) for Psoriasis: Oral Alternative to Biologics, Explained
Apremilast is one of the few systemic psoriasis treatments that comes as a tablet rather than an injection, and it has a genuinely different cost story in India than most of the biologics covered elsewhere on this site — because unlike them, it’s been officially approved and manufactured here for years.
What Is Apremilast and How Does It Work?
Apremilast, sold internationally as Otezla, is a small-molecule oral drug that inhibits an enzyme called phosphodiesterase-4 (PDE4). By blocking PDE4, it indirectly reduces the production of several inflammatory signals involved in psoriasis, including TNF-alpha and interleukins. It’s structurally and mechanistically distinct from the injectable biologics covered elsewhere on this site — apremilast is a chemical compound you swallow, not a lab-engineered antibody you inject.
Apremilast’s Approval and Availability in India
Apremilast received approval from the Drug Controller General of India (DCGI) for marketing in India in 2017, and it became one of the fastest-adopted new molecules in the Indian dermatology market shortly after, according to a review published in the Indian Dermatology Online Journal. Because it’s a small molecule rather than a biologic, generic versions manufactured domestically (including by Glenmark) are also available, which has made it considerably more accessible in India than most injectable biologics — some of which, as covered in our companion articles, aren’t commercially registered here at all.
Apremilast Dosing
Apremilast requires a gradual dose titration over the first five days to reduce gastrointestinal side effects, followed by a fixed maintenance dose:
- Day 1: 10 mg in the morning
- Day 2: 10 mg morning and evening
- Day 3: 10 mg morning, 20 mg evening
- Day 4: 20 mg morning and evening
- Day 5: 20 mg morning, 30 mg evening
- Day 6 onward: 30 mg twice daily as the standard maintenance dose
This is general label information — your prescribing doctor will confirm the exact titration schedule appropriate for you, particularly if you have reduced kidney function, which requires a lower maintenance dose.
How Effective Is Apremilast Compared to Biologics?
Apremilast is honestly a more modest performer than the IL-17 and IL-23 biologics covered elsewhere on this site — in its pivotal trials, roughly 28–41% of patients achieved PASI 75 at 16 weeks, well below the 70-90%+ response rates seen with newer biologics. Its real value lies elsewhere: it doesn’t require routine blood test monitoring the way methotrexate or cyclosporine do, it doesn’t carry the tuberculosis-screening requirements or infection risks associated with injectable biologics, and it’s taken as a pill rather than an injection. This makes it a reasonable option for patients with moderate disease who want to avoid injections, who have needle anxiety, or for whom the lab-monitoring burden of older systemics is a genuine barrier to treatment adherence.
Apremilast Cost in India
This is where apremilast genuinely stands out from the biologics covered in our other guides. Because it’s manufactured domestically as a generic, apremilast is considerably cheaper than any injectable biologic — internationally, patients sourcing Indian-manufactured generic apremilast through licensed pharmacies have reported costs in the range of roughly $85 (about ₹7,000) for a 180-tablet, 30 mg supply, a fraction of what even a single month of biologic therapy costs. For a realistic comparison against biologics, Ayurvedic protocols, and other systemic options, see our full psoriasis treatment cost guide.
Who Is Apremilast Typically Prescribed For?
Apremilast is approved for adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, and for active psoriatic arthritis. Indian dermatology literature specifically notes its value as a low-cost, low-monitoring option that can be used strategically alongside or in rotation with biologics and conventional systemic treatments in resource-limited settings — making it a genuinely practical middle-ground option between topical treatment and full biologic therapy.
Side Effects to Know
The most common side effects are gastrointestinal — diarrhea and nausea, particularly during the first two weeks of the titration period, which is precisely why the dose is stepped up gradually rather than started at full strength. Other reported effects include headache and, less commonly, weight loss and mood changes, which is why apremilast carries a caution for patients with a history of depression.
This article is for general education and does not replace a consultation with a qualified dermatologist. Dosing, candidacy, and monitoring decisions should always be made with your treating doctor.
